The PRV (priority review voucher) and accelerated approval will be huge! Very exciting times ahead.
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Grants Rare Pediatric Disease Designation for Revascor
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor, page-92
-
-
- There are more pages in this discussion • 289 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.40 |
Change
-0.065(4.44%) |
Mkt cap ! $1.581B |
Open | High | Low | Value | Volume |
$1.45 | $1.46 | $1.37 | $5.369M | 3.823M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 12877 | $1.40 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.41 | 18718 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 37100 | 1.395 |
10 | 143929 | 1.390 |
9 | 71913 | 1.385 |
11 | 146500 | 1.380 |
4 | 38650 | 1.375 |
Price($) | Vol. | No. |
---|---|---|
1.400 | 12083 | 11 |
1.405 | 27987 | 8 |
1.410 | 61693 | 9 |
1.415 | 142132 | 11 |
1.420 | 79809 | 9 |
Last trade - 13.17pm 09/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online